Working… Menu
Help guide our efforts to modernize
Send us your comments by March 14, 2020.

Bevacizumab, Temozolomide, and External Beam Radiation Therapy as First-Line Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01013285
Recruitment Status : Unknown
Verified January 2016 by Jonsson Comprehensive Cancer Center.
Recruitment status was:  Active, not recruiting
First Posted : November 13, 2009
Last Update Posted : January 21, 2016
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Jonsson Comprehensive Cancer Center

Results Submitted - Not Posted on
Results information has been submitted to by the sponsor or investigator, but is not yet publicly available (or "posted") on The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
Recruitment Status : Unknown
Actual Primary Completion Date : October 2013
Estimated Study Completion Date : January 2017
Submission Cycle Results Submitted to Results Returned after Quality Control Review
1 February 25, 2016
March 25, 2016
2 August 9, 2016
September 30, 2016
3 October 6, 2016
November 29, 2016
4 November 30, 2016
January 24, 2017
5 February 15, 2017
April 3, 2017
6 August 13, 2018
(Canceled on August 13, 2018)
May 6, 2019
May 30, 2019